Aurinia to Present at Leerink Partners 7th Annual Global Healthcare Conference
February 06 2018 - 8:00AM
Business Wire
Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today
announced that its Chief Executive Officer, Richard M. Glickman and
Celia Economides, Vice President, Corporate and Public Affairs,
will participate in a Fireside Chat at the Leerink Partners 7th
Annual Global Healthcare Conference on February 14th at 2:30pm ET.
A webcast will be available and can be accessed via the investor
section of the Aurinia website, www.auriniapharma.com. A replay
will also be archived on the site following the event.
About AuriniaAurinia is a clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are suffering
from serious diseases with a high unmet medical need. The company
is currently developing voclosporin, an investigational drug, for
the treatment of LN, FSGS, MCD and DES. The company is
headquartered in Victoria, BC and focuses its development efforts
globally. For further information, see our website at
www.auriniapharma.com.
We seek safe harbor.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180206005454/en/
Aurinia Pharmaceuticals Inc.Investors:Celia EconomidesVP,
Corporate & Public
AffairsIR@auriniapharma.comorMedia:Christopher Hippolyte,
212-364-0458Christopher.hippolyte@inventivhealth.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Apr 2023 to Apr 2024